BusinessEarth Science Tech, Inc. Announces a Successful Two-Day SOHO ExpoBy Nasdaq OMXDec 5, 2017, 1:02 PM UTC
BusinessAxim Biotechnologies Announces Phase IIa Trial Results Validating its Proprietary Cannabinoid Delivery Method for Treatment of Irritable Bowel Syndrome (IBS)By Nasdaq OMXNov 21, 2017, 2:00 PM UTC
BusinessIGC-AD1 Targeting Alzheimer’s Disease to be commercialized in early 2018 Through Medical DispensariesBy Nasdaq OMXOct 18, 2017, 12:01 PM UTC
BusinessNew U.S. Patent Allowance Granted to AXIM® Biotechnologies, Inc. for Cannabinoid Ophthalmic Solutions for Glaucoma and Conjunctivitis TreatmentBy Nasdaq OMXOct 5, 2017, 1:00 PM UTC
BusinessAXIM Biotech to Present at Rodman & Renshaw 19th Annual Global Investment Conference in New York CityBy Nasdaq OMXSep 7, 2017, 1:00 PM UTC
BusinessCURE Pharmaceutical to Participate in Panel Discussion on the Future of Clinical Research using Cannabis at The Cannabis Science Conference in Portland, ORBy Nasdaq OMXAug 29, 2017, 1:01 PM UTC
BusinessAXIM Biotechnologies Reports Second Quarter 2017 ResultsBy Nasdaq OMXAug 22, 2017, 1:01 PM UTC
BusinessCEO Chris Bunka was Interviewed on Uptick Network Discussing Company’s Positive Future ProgressBy Nasdaq OMXAug 10, 2017, 1:00 PM UTC
